|Join Nairaland / LOGIN! / Trending / Recent / New|
Stats: 2,522,309 members, 5,768,280 topics. Date: Tuesday, 04 August 2020 at 12:54 AM
Chineto Ozigbo Speaks On COVID19. Supports Anambra With N20 Million / 'beard Gang Can Give You A Vaginal Infection' - Nigerian Doctor Claims / African Doctor Performs Successful Foot Reimplantation Surgery(pics) (2) (3) (4)
|American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by SibaKeAkwaibom: 6:44pm On Jul 29|
PROFESSOR SAYS IT WORKS!
Vindicated; 12 Research Studies On Over 320,000 People! Where Are The Those Who Called Dr Stella Immanuel A Liar & A Quack?
PROF HARVEY A. RISCH, LEADING PROFESSOR OF EPIDEMIOLOG IN YALE UNIVERSITY SUPPORTS DR STELLA IMMANUEL’S CLAIM; PRESENTS 12 RESEARCH STUDIES ON OVER 320,000 PEOPLE - HYDROXYCHLOROQUINE WORKS!!!
(Studies in Brazil, Switzerland, France, America & Britain)
Opinion: To all my PhD friends, scholars and graduates. This is what you wanted. Read the entire article before you comment. Don’t exhibit your functional illiterate mind by making a silly sweeping comment, we want an intelligent discussion. I can already see many of you escaping through the window. The wind has finally opened the fowl’s Ikebe!
THE PROF WRITES:
As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.
I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.
On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, "Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis." That article, published in the world's leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety.
Physicians who have been using these medications in the face of widespread skepticism have been truly heroic. They have done what the science shows is best for their patients, often at great personal risk. I myself know of two doctors who have saved the lives of hundreds of patients with these medications, but are now fighting state medical boards to save their licenses and reputations. The cases against them are completely without scientific merit.
Since publication of my May 27 article, seven more studies have demonstrated similar benefit. In a lengthy follow-up letter, also published by AJE, I discuss these seven studies and renew my call for the immediate early use of hydroxychloroquine in high-risk patients. These seven studies include: an additional 400 high-risk patients treated by Dr. Vladimir Zelenko, with zero deaths; four studies totaling almost 500 high-risk patients treated in nursing homes and clinics across the U.S., with no deaths; a controlled trial of more than 700 high-risk patients in Brazil, with significantly reduced risk of hospitalization and two deaths among 334 patients treated with hydroxychloroquine; and another study of 398 matched patients in France, also with significantly reduced hospitalization risk. Since my letter was published, even more doctors have reported to me their completely successful use.
My original article in the AJE is available free online, and I encourage readers—especially physicians, nurses, physician assistants and associates, and respiratory therapists—to search the title and read it. My follow-up letter is linked there to the original paper.
Beyond these studies of individual patients, we have seen what happens in large populations when these drugs are used. These have been "natural experiments." In the northern Brazil state of Pará, COVID-19 deaths were increasing exponentially. On April 6, the public hospital network purchased 75,000 doses of azithromycin and 90,000 doses of hydroxychloroquine. Over the next few weeks, authorities began distributing these medications to infected individuals. Even though new cases continued to occur, on May 22 the death rate started to plummet and is now about one-eighth what it was at the peak.
A reverse natural experiment happened in Switzerland. On May 27, the Swiss national government banned outpatient use of hydroxychloroquine for COVID-19. Around June 10, COVID-19 deaths increased four-fold and remained elevated. On June 11, the Swiss government revoked the ban, and on June 23 the death rate reverted to what it had been beforehand. People who die from COVID-19 live about three to five weeks from the start of symptoms, which makes the evidence of a causal relation in these experiments strong. Both episodes suggest that a combination of hydroxychloroquine and its companion medications reduces mortality and should be immediately adopted as the new standard of care in high-risk patients.
Why has hydroxychloroquine been disregarded?
First, as all know, the medication has become highly politicized. For many, it is viewed as a marker of political identity, on both sides of the political spectrum. Nobody needs me to remind them that this is not how medicine should proceed. We must judge this medication strictly on the science. When doctors graduate from medical school, they formally promise to make the health and life of the patient their first consideration, without biases of race, religion, nationality, social standing—or political affiliation. Lives must come first.
Second, the drug has not been used properly in many studies. Hydroxychloroquine has shown major success when used early in high-risk people but, as one would expect for an antiviral, much less success when used late in the disease course. Even so, it has demonstrated significant benefit in large hospital studies in Michigan and New York City when started within the first 24 to 48 hours after admission.
In fact, as inexpensive, oral and widely available medications, and a nutritional supplement, the combination of hydroxychloroquine, azithromycin or doxycycline, and zinc are well-suited for early treatment in the outpatient setting. The combination should be prescribed in high-risk patients immediately upon clinical suspicion of COVID-19 disease, without waiting for results of testing. Delays in waiting before starting the medications can reduce their efficacy.
Third, concerns have been raised by the FDA and others about risks of cardiac arrhythmia, especially when hydroxychloroquine is given in combination with azithromycin. The FDA based its comments on data in its FDA Adverse Event Reporting System. This reporting system captured up to a thousand cases of arrhythmias attributed to hydroxychloroquine use. In fact, the number is likely higher than that, since the reporting system, which requires physicians or patients to initiate contact with the FDA, appreciably undercounts drug side effects.
But what the FDA did not announce is that these adverse events were generated from tens of millions of patient uses of hydroxychloroquine for long periods of time, often for the chronic treatment of lupus or rheumatoid arthritis. Even if the true rates of arrhythmia are ten-fold higher than those reported, the harms would be minuscule compared to the mortality occurring right now in inadequately treated high-risk COVID-19 patients. This fact is proven by an Oxford University study of more than 320,000 older patients taking both hydroxychloroquine and azithromycin, who had arrhythmia excess death rates of less than 9/100,000 users, as I discuss in my May 27 paper cited above. A new paper in the American Journal of Medicine by established cardiologists around the world fully agrees with this.
In the future, I believe this misbegotten episode regarding hydroxychloroquine will be studied by sociologists of medicine as a classic example of how extra-scientific factors overrode clear-cut medical evidence. But for now, reality demands a clear, scientific eye on the evidence and where it points. For the sake of high-risk patients, for the sake of our parents and grandparents, for the sake of the unemployed, for our economy and for our polity, especially those disproportionally affected, we must start treating immediately.
Harvey A. Risch, MD, PhD, is professor of epidemiology at Yale School of Public Health.
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by john2cool25(m): 6:48pm On Jul 29|
it's getting hotter, let see how they will react
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by potent5(m): 7:07pm On Jul 29|
We de watch.
Doctors and pharmaceutical companies always taking advantage of diseases to collude and rip people off.
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by Ekemeze: 7:15pm On Jul 29|
"Alot of Nigerians contacted the virus. but they treated it with malaria drugs. and there are just fine now."
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by DICKstractor(m): 9:57pm On Jul 29|
More chemical reactions expected
I'm not a medical expert or a scientist, let me give space for them to fight so that I can watch...
But why is our home based profs not reacting or didn't they study this part of science that treat virus?... na to fail students they Sabi. I know all of them Don buy complete protective kit; nose mask, and face shield and others
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by edoairways: 12:50am On Jul 30|
Some will still refute this claim after all WHO hasn't endorsed it.
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by nsiba: 4:56pm On Aug 01|
The two biggest threat to mankind
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by Buliwyf: 10:23pm On Aug 01|
Another nonsense thread.
So it works but people are still dying all over the place. Even people that believe it works. You think they didn't try it on Ajimobi and the rest? Why are people still dying in Russia and other countries? Is it Bill Gates and WHObor Dr Fauci that is stopping them from using Hydroxychloroquine?
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by knowhowk: 8:07am On Aug 02|
Buliwyf:. Another Nonsense Comment. Address your nonsense question to people like you .
|Re: American Epidemiology Professor Backs African Doctor's Claims On Covid19 Vaccine by Buliwyf: 8:29am On Aug 02|
You didn't answer. Because your thread is filled with mindless thoughtless nonsense. Next time think deep thoughts.
|Sections: politics (1) business autos (1) jobs (1) career education (1) romance computers phones travel sports fashion health |
religion celebs tv-movies music-radio literature webmasters programming techmarket
Nairaland - Copyright © 2005 - 2020 Oluwaseun Osewa. All rights reserved. See How To Advertise. 91